Clinical Advances in Hodgkin Lymphoma - ONA
Links shared publicly online about this topic.
- 677total visits
Clinical Advances in Hodgkin Lymphoma - ONA
View full resource at oncologynurseadvisor.com
Tags: Poison, Cancer, Lymphoma, Hodgkin Lymphoma, American Cancer Society
Most Recently Shared on December 5, 2010 at 8:15 pm By:
Clinical Advances in Hodgkin Lymphoma http://goo.gl/fb/Y64V9
Treating Canine Lymphoma
medicalnewstoday.com — “A new immunotherapy for companion dogs with advanced-stage non-Hodgkin lymphoma (NHL) has been shown to improve survival while maintaining quality of life, according to a study published in the jo” View full resource at medicalnewstoday.com
Most Recently Shared on February 9, 2012 at 9:05 am By:
Newport Beach Vet Veterinarian
New Therapy: Treating Canine Lymphoma http://t.co/lzP1xfdU kudos @mnt_veterinary
Family-centered care - Clinical Care Centers - Children's Hospital Boston
childrenshospital.org — “Dana-Farber/Children?s Hospital Cancer Center, an integrated pediatric oncology program through Dana-Farber Cancer Institute and Children?s Hospital Boston, provides?in one specialized program?all the services of both a leading cancer center and a leading pediatric hospital. The Cancer and Blood Diseases Center treats several conditions such as brain tumors, leukemia, hodgkin lymphoma, sickle cell disease, thalassemia disease, cerebrovascular disorders, and several other conditions” View full resource at childrenshospital.org
Most Recently Shared on January 11, 2012 at 12:00 am By:
Children's Hospital Hospital and Children's Hospital
Treating #cancer is scary, especially in kids, but we have a family-centered approach. Here are some details http://t.co/f1kSKKlq
Pediatric Hodgkin's Regimens Suit Adolescents and Young Adults : IMNG Oncology Report
oncologyreport.com — “The Oncology Report is an independent news source that provides oncologists with timely and relevant news and commentary about clinical developments in the field and about the impact of health care policy on the specialty and the physician's practice. The Oncology Report is owned by the International Medical News Group (IMNG) division of Elsevier.” View full resource at oncologyreport.com
Most Recently Shared on December 21, 2011 at 7:44 pm By:
Bob Finn - Medical News Net Health News
Pediatric Hodgkin's lymphoma regimens suit adolescents and young adults http://t.co/GDV6WZO1
Patients With Limited-Stage Hodgkin's Lymphoma Have Increased Survival Rates When Treated With Chemotherapy Alone
medicalnewstoday.com — “New research led by the NCIC Clinical Trials Group (CTG) at Queen's University has proven patients with limited stage Hodgkin's lymphoma have a better chance of long-term survival if they undergo” View full resource at medicalnewstoday.com
Most Recently Shared on December 14, 2011 at 12:05 pm By:
Patients With Limited-Stage Hodgkin's Lymphoma Have Increased Survival Rates When Treated With Chemotherapy Alone http://t.co/bwCWP4Mh
OncoSec and Serametrix Collaborate to Identify Potential Biomarkers to Enhance Skin Cancer Immune Therapies | Biomarker Commons
biomarkercommons.org — “OncoSec Medical Incorporated, which is developing its advanced-stage OMS ElectroOncology therapies to treat solid tumor cancers, today announced it has entered into a collaborative research agreement with Serametrix Corporation to analyze subjects in three OncoSec Phase II clinical trials treating melanoma, Merkel cell carcinoma and cutaneous T-cel” View full resource at biomarkercommons.org
Most Recently Shared on November 17, 2011 at 4:34 pm By:
New data from Pfizer's hematology portfolio to be presented at 53rd ASH annual meeting
news-medical.net — “Pfizer Oncology will present data on a number of investigational compounds from its hematology portfolio, including new data from bosutinib in chronic myeloid leukemia (CML), inotuzumab in non-Hodgkin lymphoma (NHL), as well as the first presentation of clinical data for PF-04449913, which inhibits Smoothened (SMO), a key component of the Hedgehog pathway.” View full resource at news-medical.net
Most Recently Shared on November 8, 2011 at 5:00 am By:
New data from Pfizer's hematology portfolio to be presented at 53rd ASH annual meeting: Pfizer Oncology will pre... http://t.co/RyD8kqEh
FDA: 35 innovative new drugs approved in fiscal year 2011
fda.gov — “Over the past 12 months, the U.S. Food and Drug Administration approved 35 new medicines. This is among the highest number of approvals in the past decade, surpassed only by 2009 (37). Many of the drugs are important advances for patients, including: two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin’s lymphoma in 30 years; and the first new drug for lupus in 50 years.” View full resource at fda.gov
Most Recently Shared on November 3, 2011 at 4:08 pm By:
Paul W. Thomas Health Communicator
RT @fda_drug_info: FDA: 35 innovative new drugs approved in fiscal year 2011. http://t.co/8V8E88Lr
Lymphoma Resources | Facebook
facebook.com — “Lymphoma Resources - This page is created to share timely information on Hodgkin and non-Hodgkin lymphoma and to promote awareness of novel clinical trials for lymphoma patients | Facebook” View full resource at facebook.com
Most Recently Shared on September 1, 2011 at 3:15 am By:
Anas Younes, M.D. Internist, Oncologist, Physician, and Doctor
Please follow me on Facebook to get updates on medicine, cancer and lymphoma http://t.co/9Pk5Lin and http://t.co/7KKwjf9 @addthis
Seattle Genetics initiates ADCETRIS phase II trial in CD30-positive non-Hodgkin lymphoma
news-medical.net — “Seattle Genetics, Inc. today announced that it has initiated a phase II clinical trial of ADCETRIS for patients with relapsed or refractory CD30-positive non-Hodgkin lymphomas, including diffuse large B-cell lymphoma, peripheral T-cell lymphoma and other less common lymphoma subtypes.” View full resource at news-medical.net
Most Recently Shared on August 24, 2011 at 4:49 am By:
News-Medical.Net Oncology and Health News
Oncology News: Seattle Genetics initiates ADCETRIS phase II trial in CD30-positive non-Hodgkin lymphoma: Seattle... http://t.co/HaamTzI
Seattle Genetics: RSS Content
investor.seagen.com — “Seattle Genetics: RSS Content” View full resource at investor.seagen.com
Most Recently Shared on August 23, 2011 at 3:24 pm By:
eyeonfda Pharma and Health Lawyer
Seattle Genetics Announces Initiation of Phase II Clinical Trial of ADCETRIS(TM) in CD30-Positive Non-Hodgkin #Lymphoma http://ow.ly/6axRm
Oncology Article | Lymphoma
mdlinx.com — “Clonal relationship of classical Hodgkin lymphoma and its recurrences” View full resource at mdlinx.com
Most Recently Shared on August 11, 2011 at 8:13 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Clonal relationship of classical Hodgkin lymphoma and its recurrences: Clinical Cancer Research http://bit.ly/nI8ZVc #oncology
Oncology Article | Lymphoma
mdlinx.com — “Bortezomib added to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: A phase II study by the National Cancer Institute of Canada Clinical Trials Group” View full resource at mdlinx.com
Most Recently Shared on August 4, 2011 at 7:12 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Bortezomib added to R-CVP is safe and effective for previously untreated advanced-stage follicular lym... http://bit.ly/oHXMpD #oncology
2 genetic variations predict second cancers after radiation for children with Hodgkin lymphoma
labspaces.net — “A genome-wide association study published in the August issue of Nature Medicine has found two tiny genetic variations that can predict which patients with Hodgkin's lymphoma are most likely to develop radiation-induced second cancers years after treatment. Knowing in advance who is at risk could help physicians tailor treatment to reduce the risks for patients who are most susceptible to l” View full resource at labspaces.net
Most Recently Shared on July 25, 2011 at 3:15 pm By:
2 genetic variations predict second cancers after radiation for children with Hodgkin lymphoma - http://is.gd/xjpKZt
Predicting Second Cancers After Radiation For Children With Hodgkin Lymphoma - QualityPoint Technologies
qualitypointtech.net — “A genome-wide association study published in the August issue of Nature Medicine has found two tiny genetic variations that can predict which patients with Hodgkin's lymphoma are most likely to develop radiation-induced second cancers years after treatment. Knowing in advance who is at risk could help physicians tailor treatment to reduce the risks for patients who are most susceptible to long-term damage. Hodgkin's lymphoma is one of the most treatable cancers, with more than 90 percent of pati” View full resource at qualitypointtech.net
Most Recently Shared on July 25, 2011 at 10:00 am By:
Predicting Second Cancers After Radiation For Children With Hodgkin Lymphoma: A genome-wide association study publ... http://bit.ly/pd8vxn
Chemo Toxicity May Tip Scales in Advanced Hodgkin's Lymphoma - QualityPoint Technologies
qualitypointtech.net — “Overall survival nearly evened out in a clinical trial comparing 2 chemotherapy regimens; adverse events might be a deciding factor in choosing one or the other. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on July 21, 2011 at 4:45 am By:
Chemo Toxicity May Tip Scales in Advanced Hodgkin's Lymphoma: Overall survival nearly evened out in a clinical tr... http://bit.ly/n7JzVL
Advertisement
